Lexeo Therapeutics, Inc. Common Stock Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
JANUS HENDERSON GROUP PLC | 05/15/2025 | 4.56 M | $18.62 M | 5.04% | 13.76% |
CITADEL ADVISORS LLC | 05/15/2025 | 2.72 M | $9.45 M | 0.00% | 8.22% |
BLACKROCK, INC. | 05/02/2025 | 1.84 M | $6.39 M | 1.11% | 5.56% |
AFFINITY ASSET ADVISORS, LLC | 05/14/2025 | 1.48 M | $5.14 M | 100.00% | 4.47% |
OMEGA FUND MANAGEMENT, LLC | 05/15/2025 | 1.18 M | $4.11 M | 0.00% | 3.58% |
BLACKSTONE INC. | 05/15/2025 | 1.16 M | $4.02 M | 0.00% | 3.50% |
VESTAL POINT CAPITAL, LP | 05/15/2025 | 1.14 M | $3.94 M | -5.31% | 3.43% |
NOVO HOLDINGS A/S | 05/15/2025 | 1.12 M | $3.90 M | 0.00% | 3.39% |
VANGUARD GROUP INC | 05/09/2025 | 1.10 M | $3.81 M | -1.75% | 3.32% |
POINT72 ASSET MANAGEMENT, L.P. | 05/15/2025 | 1.10 M | $3.81 M | 46.37% | 3.32% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 1.07 M | $3.72 M | 654.83% | 3.24% |
D1 CAPITAL PARTNERS L.P. | 05/15/2025 | 978.65 K | $3.40 M | -55.59% | 2.96% |
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 05/15/2025 | 955.52 K | $3.32 M | 0.00% | 2.89% |
WOODLINE PARTNERS LP | 05/15/2025 | 837.01 K | $2.90 M | -2.52% | 2.53% |
AVIDITY PARTNERS MANAGEMENT LP | 05/15/2025 | 645.00 K | $2.24 B | 100.00% | 1.95% |
SIREN, L.L.C. | 05/23/2025 | 603.44 K | $2.09 M | 0.00% | 1.82% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 586.52 K | $2.04 M | 3.37% | 1.77% |
IKARIAN CAPITAL, LLC | 05/15/2025 | 550.03 K | $1.91 M | 10.16% | 1.66% |
RA CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 546.55 K | $1.90 M | 0.00% | 1.65% |
STATE STREET CORP | 05/15/2025 | 469.73 K | $1.63 M | 2.69% | 1.42% |
VERITION FUND MANAGEMENT LLC | 05/15/2025 | 414.86 K | $1.44 M | -41.56% | 1.25% |
DAFNA CAPITAL MANAGEMENT LLC | 05/15/2025 | 378.08 K | $1.31 M | -3.82% | 1.14% |
LAURION CAPITAL MANAGEMENT LP | 05/15/2025 | 260.23 K | $902.99 K | 0.00% | 0.79% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2025 | 237.95 K | $825.70 K | -89.23% | 0.72% |
NORTHERN TRUST CORP | 05/13/2025 | 206.09 K | $715.14 K | -3.82% | 0.62% |
ADAR1 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 170.45 K | $591.46 K | 0.56% | 0.51% |
BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2025 | 163.17 K | $566.21 K | 10.40% | 0.49% |
PRIVIUM FUND MANAGEMENT B.V. | 05/09/2025 | 160.20 K | $555.89 K | 15.99% | 0.48% |
PERCEPTIVE ADVISORS LLC | 05/15/2025 | 139.84 K | $485.23 K | 0.00% | 0.42% |
TWO SIGMA ADVISERS, LP | 05/15/2025 | 96.10 K | $333.47 K | 100.00% | 0.29% |
MORGAN STANLEY | 05/15/2025 | 84.32 K | $292.58 K | 12.68% | 0.25% |
MARSHALL WACE, LLP | 05/15/2025 | 81.01 K | $281.10 K | 355.26% | 0.24% |
GOLDMAN SACHS GROUP INC | 05/16/2025 | 79.11 K | $274.51 K | -12.97% | 0.24% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 56.17 K | $194.92 K | -12.06% | 0.17% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 50.64 K | $175.74 K | -0.03% | 0.15% |
AQR CAPITAL MANAGEMENT LLC | 05/15/2025 | 50.34 K | $174.67 K | 370.00% | 0.15% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 50.15 K | $174.01 K | 349.83% | 0.15% |
BARCLAYS PLC | 05/15/2025 | 46.67 K | $163.00 K | -15.40% | 0.14% |
SHAY CAPITAL LLC | 05/15/2025 | 43.30 K | $150.24 K | 100.00% | 0.13% |
BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 40.21 K | $139.53 K | 16.46% | 0.12% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2025 | 38.40 K | $133.25 K | -40.92% | 0.12% |
TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 36.62 K | $127.09 K | 100.00% | 0.11% |
05/12/2025 | 36.05 K | $125.09 K | 100.00% | 0.11% | |
PANAGORA ASSET MANAGEMENT INC | 05/15/2025 | 34.74 K | $120.55 K | 100.00% | 0.10% |
RHUMBLINE ADVISERS | 04/08/2025 | 30.19 K | $104.75 K | 19.82% | 0.09% |
ACADIAN ASSET MANAGEMENT LLC | 05/21/2025 | 24.65 K | $85.00 K | 100.00% | 0.07% |
CITIGROUP INC | 05/12/2025 | 23.33 K | $80.95 K | -6.41% | 0.07% |
GROUND SWELL CAPITAL, LLC | 05/13/2025 | 23.12 K | $80.24 M | 100.00% | 0.07% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 21.77 K | $75.54 K | -28.33% | 0.07% |
RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 20.30 K | $70.44 K | 100.00% | 0.06% |
Lexeo Therapeutics, Inc. Common Stock institutional Ownership - FAQ's
During the previous two years, 101 institutional investors and hedge funds held shares of Lexeo Therapeutics, Inc. Common Stock. The most heavily invested institutionals were:
JANUS HENDERSON GROUP PLC: 4.56 M
CITADEL ADVISORS LLC: 2.72 M
BlackRock, Inc.: 1.84 M
Affinity Asset Advisors, LLC: 1.48 M
Omega Fund Management, LLC: 1.18 M
Blackstone Inc.: 1.16 M
84.58% of Lexeo Therapeutics, Inc. Common Stock stock is owned by institutional investors.
Institutional investors have bought a total of 28.79 M shares in the last 24 months. This purchase volume represents approximately $78.88 M in transactions.